Boiled Peanut Oral Immunotherapy for the Treatment of Peanut Allergy: a Pilot Study
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 40
Summary
- Conditions
- IgE Mediated Peanut Allergy
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 8 years and 16 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02149719
- Collaborators
- University of Sydney
- National Institute for Health Research, United Kingdom
- Investigators
- Study Chair: Dianne E Campbell, FRACP PhD The Children's Hospital at Westmead, Australia Study Director: Sam Mehr, FRACP The Children's Hospital at Westmead, Australia Principal Investigator: Paul J Turner, FRACP PhD Imperial College London